Popular Articles

Research Carried Out In Mice Will Contribute To The Study Of Hereditary Diseases That Lead To Blindness
Researchers of the University of Granada (Spain) have used a technique consisting of the induction of neuronal degeneration neuronal for intense light exposure in the mouse"s retina that will be helpful for the study of retinitis pigmentosa (RP), a group of hereditary diseases which lead to blindness and affect more than one million persons a year all over the world. In addition, the results of this research work could be very useful for the detection of new factors or molecules originated by microglial cells and related to degenerative processes of the retina.
generic viagra online
ZymoGenetics Reports Encouraging Phase 2 Results In Renal Cell Cancer For IL-21 With Nexavar(R)
ZymoGenetics, Inc. (NASDAQ:ZGEN) announced positive final results from a Phase 2 clinical trial in patients receiving 2nd or 3rd line therapy for advanced renal cell carcinoma with the combination of recombinant Interleukin 21 (IL-21) and Nexavar® (sorafenib) tablets. The combination demonstrated considerable clinical benefit, with an overall response rate (as assessed by an independent review) of 21%, a disease control rate of 82%, and progression-free survival (PFS) of 5.7 months in this heavily pretreated population. Results were presented at the American Society of Clinical Oncology meeting.
News of the day
California HIV/AIDS Advocates Continue To Protest Proposed Funding Cuts
On Monday, HIV/AIDS advocates staged a rally in Fresno, Calif., to protest a budget proposal by Gov. Arnold Schwarzenegger (R) that would cut an estimated $80 million statewide in HIV/AIDS services, KMPH.com reports. The proposed cuts would eliminate or reduce funding for HIV testing services, financial assistance for people living with HIV and other programs, according to KMPH.com. A larger rally at the state capitol is planned for Wednesday (KMPH.com. 6/9).
Oncology

Pharmaceutical Society of Australia Welcomes New Health Portfolio

The announcement of the establishment of a new Indigenous Health, Rural and Regional Health and Regional Services Delivery portfolio has been welcomed by the Pharmaceutical Society of Australia. President of the PSA, Warwick Plunkett, said the establishment of the new portfolio was recognition of the unique and challenging issues faced by indigenous health consumers as well as those living in non-urban areas of Australia. "Often people living in rural, regional and remote areas of Australia face enormous difficulties when it comes to their health-care needs," Mr Plunkett said. "In addition, indigenous health has its own unique challenges which the establishment of this portfolio will go a long way towards addressing. "The PSA, as the organisation that represents the professional interests of pharmacists across the nation, is well aware of these difficulties and has long advocated policies and programs to help address them. "The establishment the Indigenous Health, Rural and Regional Health and Regional Services Delivery portfolio gives the Government and health-care professionals in Australia a vehicle from which to work to improve the health needs and outcomes of indigenous Australians and those living in non-urban areas." Mr Plunkett said the appointment of Mr Warren Snowdon as Minister for Indigenous Health, Rural and Regional Health and Regional Services Delivery underscored the importance of the portfolio. "Mr Snowdon is a widely experienced politician and as a member for a rural area has first-hand knowledge and experience of some of the issues and difficulties faced by consumers in these areas," Mr Plunkett said. "On behalf of the PSA, I congratulate Mr Snowdon on his appointment and look forward to working closely with him and his new department to help achieve the outcomes that people in these areas so demonstrably need." Pharmaceutical Society of Australia


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):